PROGRAMME
Kindly note that the programme will still be subject to changes.
Thursday, October 22, 2026
Room 1
08:00-09:00
AI in cardiovascular imaging: The time is now?! (All Levels)
Moderators: C. Loewe, Vienna/AT | J. Weir McCall, Cambridge/UK
Strengths and challenges of AI in imaging
K. Hanneman, Toronto/CA
AI in cardiac CT: Current role, future outlook
K. Nikolaou, Tuebingen/DE
AI in cardiac MRI: Current role, future outlook
A. Swift, Sheffield/UK
Q&A
09:00-09:05 Break
09:05-10:05
ESCR meets NASCI: Aorta imaging and beyond (All Levels)
Moderators: R. Budde, Rotterdam/NL | K. Hanneman, Toronto/CA
ESCR aortic imaging practice recommendations
N. Galea, Rome/IT
Non-invasive imaging in peripheral arterial occlusive disease
P. Rajiah, Rochester/US
How does PCCT change vascular imaging?
K. Hanneman, Toronto/CA
Q&A
10:05-10:20 Pitch Session: From innovation to impact – Part I
Moderator: R. Vliegenthart, Groningen/NL
10:20-10:50 Break
10:50-11:00
Opening Ceremony
Moderator: M. Francone, Rome/IT | R. Salgado, Antwerp/BE
Introduction & Welcome to Rotterdam
R. Vliegenthart, Rotterdam/NL
11:00-12:00
Opening Session: Connect to Impact
Moderators: M. Francone, Rome/IT | R. Salgado, Antwerp/BE
ESCR: Connecting cardiovascular radiologists
M. Francone, Rome/IT
The EU Safe Hearts plan: where does imaging fit in?
R. Salgado, Antwerp/BE
From diagnosis to prevention in Europe
R. Vliegenthart, Groningen/NL
12:00-12:10 Break
12:10-12:55 Industry Symposium
12:55-13:20 Break
13:20-14:35
Update on ischemia imaging (All Levels)
Moderators: J. Habets, Nieuwegein/NL | P. van der Harst, Groningen/NL
Guidelines on ischemia imaging in CAD management
R. Nijveldt, Nijmegen/NL
Current role of FFR-CT and CT perfusion
J. Weir-McCall, London/UK
Update on myocardial perfusion MRI
G. Bastarrika, Pamplona/ES
MRI to assess coronary vascular (dys)function
M. Friedrich, Montreal/CA
Q&A
14:35-14:40 Break
14:40-15:05 Industry Slot
15:05-15:35 Break
15:35-17:05
ESCR meets other imaging societies (All Levels)
Moderators: M. Francone, Rome/IT | R. Vliegenthart, Groningen/NL
Radiographers: role in cardiac imaging
P. Cornacchione, Rome/IT (EFRS)
Towards high-value, sustainable cardiac imaging
K. Hanneman, Toronto/CA (RSNA)
Updates on cardiac CT/MRI in European guidelines
R. Nijveldt, Nijmegen/NL (EACVI)
MRI trials with impact on clinical routine
V. Ferreira, Oxford/UK (SCMR)
CT trials with clinical diagnostic impact
J. Weir-McCall, London/UK (SCCT)
Role of PET/SPECT in cardiac diagnosis and management
P.A. Erba, Milan/IT (EANM)
Q&A
17:10-18:10
Crack the Case: An Interactive Cardiovascular Imaging Quiz
M. Halfmann, Mainz/DE | G. Tremamunno, Rome/IT | E. Zsarnoczay, Budapest/HU
Room 2
08:00-09:00
Scientific Session 1: Cardiac MR imaging – Tissue characterization at its best
Moderators: C. Glessgen, Geneva/CH | J. Luetkens, Bonn/DE
Agreement between cardiac CT and CMR for left ventricular morpho‑functional assessment and myocardial strain in STEMI: a sub‑study of the CT‑STEMI trial
S. Moballeghi, Turin/IT
MRI-derived wall thickness heterogeneity in hypertrophic cardiomyopathy and in carriers of sarcomeric gene mutations
M. Alberti, Pisa/IT
Non-Contrast CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis Using Myocardial Strain and Left Ventricular Remodeling Index
E. Pershina, Moscow/RU
Liver T1 in Cardiac MRI: A Novel Predictor of Heart Failure and MACE
A. Peters, Bern/CH
Native T1 and myocardial strain in transfusion-dependent thalassemia with preserved LVEF and normal myocardial T2* values.
N. Pegoraro, Ferrara/IT
Improved detection of RV fibrosis using dark-blood LGE CMR and impact on arrhythmogenic right ventricular cardiomyopathy diagnosis
R. Holtackers, Maastricht/NL
Shape analysis study of the left ventricle in adult patients who underwent the arterial switch operation using statistical shape modelling
T. Hanna, Bristol/UK
09:00-09:05 Break
09:05-10:05
Scientific Session 2: Cardiac CT imaging I – Pushing the boundaries
Moderators: M. Halfmann, Mainz/DE | G. Muscogiuri, Bergamo/IT
Illuminating the unseen: detecting myocardial fibrosis with photon-counting detector CT
M.J. Lemmens, Maastricht/NL
Non-invasive imaging of cardiac allograft vasculopathy and myo-cardial composition in heart transplantation. A prospective ex-ploratory study using cardiac Photon-Counting Computed Tomography (PCCT)
D. Beitzke, Vienna/AT
Improving Coronary Plaque Classification with Ultra–High-Resolution Photon-Counting CT Compared with Standard-Resolution Imaging: Validation against Optical Coherence Tomography and Histology
Y. Wang, Beijing/CN
Impact of slice thickness in photon-counting CT on the detectability of coronary artery calcium
M. Papavasileiou, Groningen/NL
Relative Electron Density (RED) from Constrained Multienergy Material Decomposition Outperforms HU and Zeff for Identifying Lipid-Rich Necrotic Core from Fibrous Plaque in Dual-Energy CT: A Phantom Study
G. Wesbey, La Jolla/US
Point-by-Point Co-Registration of Photon-Counting CT and Electro-Anatomical Mapping for Structural Substrate Characterisation in Ventricular Tachycardia
A. Colombo, Milan/IT
Ultra-High-Resolution Photon-Counting CT for the assessment of hypoattenuated leaflet thickening after Transcatheter Aortic Valce Replacement
A. Kilburg, Mainz/DE
10:05-13:20 Break
13:20-14:35
Imaging in cardio-oncology: Staying on top of treatment strategies (Advanced)
Moderators: A. Buz Yasar, Bolu/TR | B. Wintersperger, Toronto/CA
Imaging cardiac effects of non-immunotherapy systemic cancer therapies
A. Jacquier, Marseilles/FR
Cardiac MRI in cancer immunotherapy: Are biopsies outdated?
J. Luetkens, Bonn/DE
Imaging of radiation‐induced coronary artery disease
E. Mousseaux, Paris/FR
Role of nuclear imaging in cardio-oncology
A. Weustink, Rotterdam/NL
Q&A
14:35-15:35 Break
15:35-17:05
Basics of cardiac CT and MRI: Technical details explained (Basic)
Moderators: R. Takx, Amsterdam/NL | E. Zsarnoczay, Budapest/HU
MRI for tissue characterization
M. Hrabak Paar, Zagreb/HR
Contrast media injection protocols for EID-CT and PC-CT
C. Mihl, Maastricht/NL
Stress MRI perfusion – Pearls and pitfalls
S. Ley, Munich/DE
Stress perfusion CT – Static and dynamic
T. Emrich, Mainz/DE
4D flow MRI – When and how
J. Westenberg, Leiden/NL
Q&A
Friday, October 23, 2026
Room 1
Moderators: J. Carvalho, Porto/PT, R. Vliegenthart,Groningen/NL
CT at initial presentation in the ED: Can we exclude CAD?
R. Salgado, Antwerp/BE
MRI: Is it MINOCA/Takotsubo/myocarditis…?
M. Pirnat, Maribor/SI
Imaging in OHCA: How and why?
B.K. Velthuis, Utrecht/NL
Q&A
Updates on lung cancer screening
E. Kočová, Hradec Kralove/CZ
Coronary calcium evaluation on chest CT?
ESTI/ESCR consensus on imaging pulmonary hypertension
Q&A
Moderators: M. Halfmann, Mainz/DE | M. Gutberlet, Leipzig/DE
J. Shambrook, Southampton/UK
Risk stratification and follow-up in cardiomyopathies
B. Wintersperger, Toronto/CA
Pediatric cardiomyopathies
P. Agarwal, Minneapolis/US
Diving into hypertrophic phenotypes
C. Gkizas, Lille/FR
Arrhythmogenic cardiomyopathy: A moving target
L. Natale, Rome/IT
Q&A
Moderators: M. Francone, Rome/IT | R. Salgado, Antwerp/BE
Honorary Session: Impact of cardiovascular radiology
M. Francone, Rome/IT
Best Paper Awards
B. Hamm, Berlin/DE
European Radiology: Ultra-high-resolution photon-counting detector CT in evaluating coronary stent patency: a comparison to invasive coronary angiography
M.T. Hagar, Charleston/US
European Radiology – Experimental: Impact of reconstruction parameters on the accuracy of myocardial extracellular volume quantification on a first-generation, photon-counting detector CT
C. Gnasso, Milan/IT
European Radiology Journals
B. Hamm, Berlin/DE
Moderators: R. Vliegenthart, Groningen/NL
Moderators: F. Secchi, Milan/IT | G. Staskiewicz, Lublin/PL
M. Williams, Edinburgh/UK
Stent assessment: Current status
H. Alkadhi, Zurich/CH
Cardiac fat measures: Ready for implementation?
P. Maurovich-Horvat, Budapest/HU
How does PCCT change coronary CTA beyond stenosis?
S. Boccalini, Rouen/FR
Q&A
Moderators: V. Groudeva, Sofia/BG | L. Natale, Rome/IT
R. Salgado, Antwerp/BE
Free breathing MRI – Uncooperative patients/young children
G. Muscogiuri, Bergamo/IT
Towards non-contrast cardiac MRI
M. Friedrich, Montreal/CA
Imaging in presence of pacemaker/ICD
J. Bremerich, Basel/CH
Rapid, undersampled MRI
A. Chiribiri, London/UK
Q&A
Room 2
08:00-09:00
Scientific Session 3: Cardiac CT imaging II – Pushing the boundaries
Moderators: H. Alkadhi, Zurich/CH | M. Tregubova, Kyiv/UA
Prognostic value of quantitative Photon-Counting CT biomarkers in Cardiac Allograft Vasculopathy after Heart Transplantation
C. Gkizas, Lille/FR
Role of Coronary CT Angiography (CCTA) in the Preoperative Assessment of Coronary Artery Disease (CAD) in Patients with Aortic Infective Endocarditis (IE) Undergoing Valve Surgery
G. Rovere, Rome/IT
Coronary Artery Plaque Composition and Structure: A Plaque-to-Plaque Comparison Between Energy-Integrating Detector CT and Photon-Counting CT
W-J. Lee, Taipei City/TW
CT-Derived Artificial Intelligence Improves Detection of Pulmonary Hypertension Compared with Echocardiographic Risk Stratification
M. Sharkey, Sheffield/UK
Photon-Counting Detector Cardiac CT for Hemodynamic Assessment of Valve Dysfunction after Transcatheter Aortic Valve Replacement
S. Hyska, Charleston/US
Prognostic Value of a Coronary CT Angiography-based Fractional Flow Reserve Deep Learning Model for Predicting Cardiovascular Events: Comparison with Invasive FFR and iFR
L. Bijnens, Leuven/BE
Cardiac CT in the Acute Stroke Protocol: Left Atrial Enhancement Patterns and Embolic Source Detection in Anticoagulated Patients with Atrial Fibrillation
E. Baettig, Barcelona/ES
09:00-09:05 Break
09:05-10:05
Poster Session
Moderators: G. Francese, Rouen/FR | B. Wintersperger, Toronto/CA
Cardiac Magnetic Resonance Features of SLC25A4‑Related Mitochondrial Cardiomyopathy
L. Musayeva, Baku/AZ
Noonan syndrome: Evaluation of cardiovascular abnormalities using CT and MRI
E. Jellin, Zagreb/HR
Role of Cross-Sectional Imaging in Transcatheter Repair of PAPVR with Sinus Venosus Defect
H. Sudarsan, Liverpool/UK
More than meets the eye: distinguishing true hypertrophy from phenotypic mimics
A. Boulmpou, Nijmegen/NL
When Hounsfield Units Lie: Chylopericardium – A rare entity
F. Cano Mateos, Donostia-San Sebastián/ES
Same Scan, Different Answers: Where You Measure Matters in Congenital Heart Disease MRI
S. Priya, Madison/US
Pericoronary Adipose Tissue on CCTA for Prediction of MACE: Systematic Review and Meta-Analysis
D. Verna, Turin/IT
Comparison of standard and experimental T2 Mapping sequences for myocardial tissue characterization in cardiac MRI
F. Edelmann, Tuebingen/DE
Pericoronary Adipose Tissue Changes in Rapid Cardiac Allograft Vasculopathy Assessed by CCTA
M. Boussoussou, Budapest/HU
Genotype–phenotype interplay in hypertrophic cardiomyopathy: the added value of cardiac magnetic resonance (cmr)
L. M. De Sanctis, Rome/IT
High Attenuation Artifact Stress Testing Reveals Differences in Robustness of Relative Electron Density and Effective Atomic Number in Spectral CT
G. Wesbey, La Jolla/US
10:05-10:35 Break
10:35-12:05
Imaging for cardiovascular intervention planning (All Levels)
Moderators: M. Hrabak Paar, Zagreb/HR | M. Pop, Targu-Mures/RO
Workup for mitral valve/LAA interventions
A. Esposito, Milan/IT
MRI guided interventions: Realtime imaging fusion
M. Guglielmo, Utrecht/NL
Workup for ablation of arrhythmias
J. E. Lee, Seoul/KR (KOSCI)
Workup for TAVI
C. Celeng, Utrecht/NL
CCTA/CT-FFR to guide coronary intervention planning?
F. Catapano, Milan/IT
Q&A
12:05-14:15 Break
14:15-15:30
Connecting disciplines: The radiologist connected to… (All Levels)
Moderators: J. Bremerich, Bern/CH | J. Habets, Nieuwegein/NL
The pulmonary oncologist (cardiac invading tumors)
G. Tremamunno, Rome/IT
The cardiogeneticist (genetic CMP)
A. Hirsch, Rotterdam/NL
The infectious disease specialist (inflammation/endocarditis)
J. Broncano, Cordoba/ES
The neurologist (cardioembolic stroke)
B. Velthuis, Utrecht/NL
Q&A
15:30-16:30 Break
16:30-18:00
How to read congenital heart disease imaging: Case-based (Advanced)
Moderators: M. Pirnat, Maribor/SI | T. Yalynska, Kyiv/UA
Grown ups with (incidental) CHD
A. Spijkerboer, Amsterdam/NL
Tetralogy of Fallot
A. Secinaro, Rome/IT
Shunts: ASD, VSD, PAPVR…
F. Zuccarino, Barcelona/ES
Transposition of the great arteries
T. Semple, London/UK
Q&A
Saturday, October 24, 2026
Room 1
Guidelines: Role of CT/MRI in valvular heart disease
A. Hirsch, Rotterdam/NL
Updates in echocardiography for valvular imaging
K. Sienkiewicz, Gdansk/PL
Valvular imaging: 4D-flow MRI and beyond
A. Azarine, Paris/FR
Q&A
Moderators: C. Mihl, Maastricht/NL | N. Almeida Aróstegui, Madrid/ES
M. Williams, Edinburgh/UK
Spectral CT imaging: When is it helpful?
F. Pontana, Lille/FR
Standardization of CT reporting: How to – role for AI?
M. Van Assen, Atlanta/US
Q&A
Imaging of post-procedural complications: Case-based (All Levels)
Moderators: T. Emrich, Mainz/DE | B. Wintersperger, Toronto/CA
Imaging after treatment of thoracic aorta
C. Loewe, Vienna/AT
Imaging after cardiac transplantation/LVAD
R. Budde, Rotterdam/NL
Imaging after arrhythmia ablation
M. Eberhard, Zurich/CH
Post-valvular intervention imaging
N. Fink, Munich/DE
Q&A
Moderators: T. Mittal, London/UK | F. Pontana, Lille/FR
Role of MRI in heart failure guidelines
M. Francone, Milan/IT
MRI tissue characteristics in ischemic cardiomyopathy
MRI tissue characteristics in non-ischemic cardiomyopathies
A. Palmisano, Milan/IT
MRI: Role in myocarditis
M. Gutberlet, Leipzig/DE
Strain MRI: When, how, and why?
R. Manka, Zurich/CH
Q&A
15:25-15:30 Break
Closing Ceremony
M. Francone, Rome/IT | R. Salgado, Antwerp/BE | R. Vliegenthart, Groningen/NL
Room 2
Moderators: G. Tremamunno, Rome/IT | M. Vecsey-Nagy, Charleston/US
N. Lama, Athens/GR
MRI: Signal artifacts
R. Holtackers, Maastricht/NL
CT: Motion, trigger, stent and device artifacts
M. Dijkshoorn, Rotterdam/NL
Q&A
Moderators: S. Boccalini, Rouen/FR | R-A. Licu, Targu-Mures/RO
B. Ghaye, Brussels/BE
Pearls in imaging for diagnosis of acute aortic syndrome
D. Suchá, Utrecht/NL
Triple rule out CT: When to consider?
S.M. Ko, Wonju/KR
Q&A
Impact of metabolic syndrome on the heart
H. Lamb, Leiden/NL
Comprehensive CT/MRI evaluation of vasculitis
J. H. Choe, Seoul/KR
The heart in auto-immune and connective tissue diseases
A. Kurata, Toon/JP
Update on MR/CT imaging of amyloidosis
D. Beitzke, Vienna/AT
The great mimicker: Sarcoidosis
M. Hol, Utrecht/NL
Q&A
Moderators: A. Luca, Bukarest/RO | J. Niemierko, Gdansk/PL
Beyond the obvious: Concomitant pathologies in cardiac MRI
V. Mergen, Zurich
The case that taught me to keep asking
M. Halfmann, Mainz/DE
A diagnostic challenge in a pregnant woman: The role of time in diagnosis
S. Seitun, Genoa/IT
When suspected myocarditis took a completely different turn
A. Isaak, Bonn/DE
Not every intracardiac mass is what it seems
A. Varga-Szemes, Charleston/US
Recurrent embolic events in a patient with an atypical left atrial mass
A. Bartoli, Marseille/FR
Not just an athlete’s heart: The diagnostic value of clinical and imaging follow-up
C. Lisi, Milan/IT
Expect the unexpected: A pediatric case study
R. Takx, Amsterdam/NL
POTENTIAL CONFLICT OF INTEREST DISCOSURE
It is the policy of the ESCR to ensure balance, independence, objectivity, and scientific rigour in the congress programme. Knowledge of possible relationships with sponsors of any kind is mandatory in order to reinforce the educational and scientific message and to relieve any suspicion of bias.
Any potential conflict of interest involving the organising committee should be made known so that the audience may form their own judgements about the presentation with a full disclosure of the facts. It is for the audience to determine whether the presenter’s external interest may reflect a possible bias in either the work carried out or the conclusions presented.
Potential conflict of interest of the congress president:
Siemens Healthineers, Bayer Healthcare, Keya Medical, Wiley